Related Experiment Video
Updated: Jan 7, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Temporal trends in heart failure and stroke-related mortality in the United States, 1999-2023
Abdur Rafay Bilal1, Maryam Sajid2, Shaheer Qureshi2
1Ziauddin Medical College, Karachi, Pakistan.
Insights
Mortality from heart failure and stroke declined until 2019 but has since increased, particularly in younger, male, and minority populations. Recent trends highlight urgent needs for improved health equity and access to care.
Area of Science:
- Cardiovascular epidemiology
- Public health surveillance
Background:
- Heart failure (HF) and stroke are leading causes of cardiovascular mortality in the U.S.
- The combined impact of HF and stroke on mortality trends has been understudied nationally.
Purpose of the Study:
- To investigate temporal, demographic, and geographic trends in stroke-related deaths among individuals with heart failure from 1999 to 2023.
- To identify disparities in mortality rates and trends across different population subgroups and regions.
Main Methods:
- Utilized CDC WONDER database for multiple cause-of-death records (adults ≥25 years) listing both HF and stroke.
- Calculated age-adjusted mortality rates (AAMRs) per 100,000 using the 2000 U.S. standard population.
- Employed joinpoint regression to analyze trends and average annual percent changes (AAPCs).
Main Results:
- Observed 465,695 deaths attributed to both HF and stroke between 1999 and 2023.
- AAMRs decreased from 13.46 in 1999 to 7.19 in 2019, then rose to 8.69 by 2023.
- Higher AAMRs noted in men, NH Black individuals, younger adults (25-44), the South, and rural areas, with slower declines and earlier increases in these groups.
Conclusions:
- Despite overall long-term declines, recent increases in stroke-related mortality among HF patients, especially post-pandemic, signal critical issues.
- Disparities persist and are worsening among younger, male, and racially minoritized populations.
- Urgent attention to health equity and access is required to address these concerning mortality trends.
Background:
Heart failure (HF) and stroke remain among the leading causes of cardiovascular mortality in the U.S. However, the intersection of these two conditions has been underexplored in national mortality data. This study investigates temporal, demographic, and geographic trends in stroke-related deaths among individuals with HF from 1999 to 2023.
Methods:
Using the CDC WONDER database, we extracted multiple cause-of-death records for adults ≥25 years where both HF and stroke were listed. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated using the 2000 U.S. standard population. Joinpoint regression identified significant trends and calculated average annual percent changes (AAPCs).
Results:
From 1999 to 2023, 465,695 deaths were attributed to both HF and stroke. AAMRs declined steadily from 13.46 in 1999 to a low of 7.19 in 2019 (AAPC: -3.2%; 95% CI: -3.3 to -3.0; p < 0.001) but then increased to 8.69 by 2023. Men had consistently higher AAMRs than women (2023: 9.88 vs. 7.71). NH Black individuals experienced the highest AAMRs (13.79 in 2023), slower declines, and an earlier mortality crossover compared to other groups. Adults aged 25-44 exhibited the steepest increase. Geographically, the South and rural counties bore the highest burden.
Conclusion:
Despite long-term mortality declines, recent reversals-especially post-pandemic and among younger, male, and racially minoritized populations-signal urgent gaps in equity and access.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management